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Introduction {#sec001}
============

Hematopoiesis is an essential cellular process in which hematopoietic stem cells (HSCs) differentiate into the multitude of different cell lineages that comprise mature blood\[[@pone.0196872.ref001]--[@pone.0196872.ref003]\]. HSCs must self-renew and persist for an organism's lifespan to replenish the mature, post-mitotic blood cells that are constantly being recycled, ensuring that the system is never depleted\[[@pone.0196872.ref004], [@pone.0196872.ref005]\]. The control of this recycling and replacement of blood cells is regulated by an intricate set of signaling molecules and molecular pathways, many of which are still enigmatic. Improper regulation of hematopoiesis can result in serious diseases such as anemia, thrombocytopenia, neutropenia, and leukemia, so understanding these signaling pathways is of clinical relevance.

In vertebrates, HCSs first arise from hemogenic endothelium located in the floor of the dorsal aorta\[[@pone.0196872.ref006]--[@pone.0196872.ref013]\]. This occurs at embryonic day (E) 10.5 in mice\[[@pone.0196872.ref006]\], between E27-40 in humans\[[@pone.0196872.ref014]\], and between 36--52 hours post fertilization (hpf) in the developing zebrafish embryo\[[@pone.0196872.ref007], [@pone.0196872.ref008]\]. Lineage tracing studies in zebrafish\[[@pone.0196872.ref007]\] and mice\[[@pone.0196872.ref015], [@pone.0196872.ref016]\] indicate that the HSCs that arise during this time give rise to all hematopoietic cells for the organism's lifespan. Importantly, studies in mice and humans indicate that HSCs don't directly differentiate into mature blood cells. Instead, they differentiate into populations of restricted hematopoietic stem and progenitor cells (HSPCs); common lymphoid progenitors (CLPs)\[[@pone.0196872.ref017], [@pone.0196872.ref018]\], which eventually produce T, B, and natural killer (NK) cells, and common myeloid progenitors (CMPs)\[[@pone.0196872.ref019], [@pone.0196872.ref020]\] that eventually generate granulocytes, erythrocytes, macrophages, and platelets. Downstream of CMPs are megakaryocyte erythroid progenitors (MEPs) that generate erythrocytes and platelets, and granulocyte macrophage progenitors (GMPs) that generate basophils, eosinophils, neutrophils, and macrophages\[[@pone.0196872.ref019], [@pone.0196872.ref020]\]. Together these HSPCs help maintain the multitude of blood cells in healthy adult organisms.

HSPC differentiation is a developmentally restrictive process, controlled by a multitude of cytokines. These small, extracellular proteins influence HSPCs to self-renew and/or undergo stepwise differentiation into mature blood cell lineages and are secreted in hematopoietic niches, mainly by stromal cells that are found in hematopoietic-supportive tissues and organs (reviewed in \[[@pone.0196872.ref021]--[@pone.0196872.ref023]\]). These factors then bind to receptors on the surface of HSPCs to mediate a multitude of different downstream cellular responses. Identification and elucidation of the downstream molecular events activated by cytokines is of key interest due to their essential role in hematopoietic regulation; improper differentiation of HSPCs can lead to an accumulation of immature cells, causing the development of lymphoma and leukemia.

To study hematopoiesis and HSPC biology, many laboratories utilize *Danio rerio* (zebrafish), which have become a promising model system for many reasons (reviewed in \[[@pone.0196872.ref024], [@pone.0196872.ref025]\]). First, they are the phylogenetically lowest vertebrate model system that has a similar circulatory and hematopoietic system to humans, including adaptive immunity (reviewed in \[[@pone.0196872.ref026]\]). Secondly, zebrafish are transparent and develop *ex utero*; within 48 hpf functional HSPCs are present\[[@pone.0196872.ref007], [@pone.0196872.ref008], [@pone.0196872.ref027]--[@pone.0196872.ref030]\]. Due to the fact that a multitude of hematopoietic-specific fluorescent transgenic zebrafish lines currently exist (reviewed in \[[@pone.0196872.ref024], [@pone.0196872.ref031]\]), HSPCs can be visualized, isolated, and studied in early embryos, a feat not possible in mammals. The fact that zebrafish are fecund, generating hundreds of embryos per clutch, allows large sample sizes and experimental replication. Finally, because zebrafish develop quickly and externally, they are excellent for mutagenesis studies\[[@pone.0196872.ref032]--[@pone.0196872.ref036]\] and screening compounds that have utility for treating human diseases\[[@pone.0196872.ref037]--[@pone.0196872.ref041]\]. For all of these reasons, the zebrafish has become a powerful model for studying normal hematopoiesis and its dysregulation during disease.

HSPCs, the cells mutated during the onset of hematopoietic disease, are not easily grown with traditional cell culture techniques because they require specific microenvironments and cytokine signals to keep them proliferating and to encourage their differentiation into mature blood cells. Studies performed in mice\[[@pone.0196872.ref042]--[@pone.0196872.ref045]\] and humans\[[@pone.0196872.ref046], [@pone.0196872.ref047]\], isolating and growing HSPCs on stromal cell lines, were important for elucidating cytokines and other signaling molecules required for HSPC proliferation and differentiation. The recent generation of hematopoietic-supportive zebrafish stromal cell lines from sites of embryonic\[[@pone.0196872.ref048], [@pone.0196872.ref049]\] and adult\[[@pone.0196872.ref050]\] hematopoiesis now allows functional testing of HSPCs in zebrafish. Putative hematopoietic-supportive factors expressed in zebrafish cell lines have been identified with RNA sequencing (RNA-seq), comparing the transcriptome of these cells to that of non-hematopoietic supportive zebrafish stroma\[[@pone.0196872.ref048]\]. Additionally, comparison of their transcriptome to mammalian hematopoietic-supportive stroma allows investigation of transcripts conserved throughout vertebrate evolution\[[@pone.0196872.ref051]\].

One interesting transcript uniquely upregulated in all hematopoietic-supportive zebrafish cell lines was isthmin 1 (*ism1)*, a gene first identified in the midbrain--hindbrain boundary (MHB) of *Xenopus\[[@pone.0196872.ref052]\]. ism1* is expressed in lymphocytes,\[[@pone.0196872.ref053]\] bone marrow\[[@pone.0196872.ref054]\], and in embryonic blood islands\[[@pone.0196872.ref052]\], and encodes a secreted 60 kDa protein containing a copy of the thrombospondin repeat (TSR) region, a domain involved in cell migration and tissue remodeling\[[@pone.0196872.ref055]\]. Importantly, it is also expressed in mouse and chicken lateral plate mesoderm, tissue which gives rise to blood in the developing embryo\[[@pone.0196872.ref054]\]. *ism1* is also implicated in angiogenesis; addition of ISM1 protein into matrigel plugs with murine tumors resulted in decreased endothelial capillary networks and decreased overall tumor growth\[[@pone.0196872.ref055]\]. Additionally, *ism1* morphant zebrafish exhibit decreased inter-segmental vessels (ISVs)\[[@pone.0196872.ref055]\]. Importantly, *ism1* levels are increased in response to the upregulation of Wnt signaling\[[@pone.0196872.ref056]\], implicating its role in early embryonic processes such as cell fate specification, migration, and the beginning of definitive hematopoiesis. Finally, *ism1* is co-expressed with fibroblast growth factor ligands that are essential for HSC specification during this developmental period\[[@pone.0196872.ref052]\]. *ism1*'s high expression within hematopoietic-supportive stromal cell lines coupled with its expression during development in blood-forming tissues and co-expression with essential hematopoietic factors indicated that *ism1* was potentially involved in the formation and modulation of HSPCs.

To understand *ism1*'s role within developmental hematopoiesis, we performed loss-of-function experiments, which indicate that *ism1* morphants have reduced mature erythroid and myeloid cells. Additionally, *ism1* morphants show reduced numbers of HSPCs present in developing fish. Overall, these data indicate that *ism1* is an important gene for the formation of the embryonic zebrafish hematopoietic system.

Materials and methods {#sec002}
=====================

Zebrafish {#sec003}
---------

Wildtype (AB) and transgenic zebrafish lines (*gata1a*:DsRed\[[@pone.0196872.ref057]\], *mpx*:EGFP\[[@pone.0196872.ref058]\], and *kdrl*:EGFP\[[@pone.0196872.ref059]\]) used in these studies were raised and maintained in accordance with California State University, Chico IACUC guidelines. All experiments were approved by the IACUC committee before being performed.

*ism1* sequence read counts {#sec004}
---------------------------

All sequenced libraries were processed and analyzed as previously described\[[@pone.0196872.ref048]\].

Generation of *ism1* mRNA {#sec005}
-------------------------

*ism1* transcript was amplified from zebrafish kidney cDNA using the following *ism1* primers: FWD `5’-ATGGTGCGTCTGGCGGCGGAG-3’` and REV `5’-TCAAAACTCCCGGGCCTCTTCA-3’`. *ism1* transcript was cloned into a TOPO-TA vector (Invitrogen, Carlsbad CA) and validated by Sanger sequencing. *ism1* was than subcloned into pCS2^+^ and linearized with Not1. *ism1* mRNA was generated using a mMessage SP6 kit (Ambion, Austin, TX).

Morpholino and *ism1* mRNA injections {#sec006}
-------------------------------------

*ism1* antisense morpholino (MO) was designed against the 5' untranslated region (UTR) and start codon to prevent translation of *ism1* mRNA (Gene Tools, Philomath, OR). The MO sequence is as follows: `5’-CCAGACGCACCATCCTCTTCACC-3’`. For microinjection into embryos, a mix of 8 μL of 7.6 mg/mL of *ism1* MO was mixed with 0.6 μL of phenol red for a final concentration of 7.0 ng/nL of *ism1* MO. 1 μL of this mix was loaded into a needle made with a PM102 micropipette puller (MicroData Instrument, Plainfield, NJ). Single-cell stage embryos were collected, placed onto a 1% agarose microinjection chamber plate with troughs, and injected with 1 nL (7.0 ng) of *ism1* MO with a PM 1000 Cell Microinjector (MicroData Instrument, Plainfield, NJ). For rescue injections, phenol red was reduced to 0.2 μL, and 0.4 μL of 44.7 ng/μL *ism1* mRNA was added. In this way, rescued embryos received 7.0 ng of *ism1* MO and 17.88 ng of *ism1* mRNA.

Microscopic visualization of the hematopoietic system {#sec007}
-----------------------------------------------------

To discern hematopoietic phenotypes and to quantitate cell lineages, florescent microscopy was utilized. Transgenic zebrafish were visualized under a Leica M165C (Leica, Wetzlar, Germany) fluorescent dissecting microscope at time points correlated with the emergence of specific hematopoietic cell lineages. Erythrocytes were visualized at 48 hpf with *gata1a*:DsRed transgenic animals and further examined by flow cytometry. Neutrophils and macrophages were visualized and individual cells were counted under the microscope at 48 hpf with *mpx*:GFP transgenic animals. Zebrafish and their fluorescently labeled cells were imaged using a Leica FireCam camera (Leica, Wetzlar, Germany), scored, and enumerated. For myeloid quantitation, images were labeled by a reference number and the numbers of *mpx*:GFP^+^ cells were counted in each animal by several undergraduate students to insure no bias in results.

Flow cytometry {#sec008}
--------------

To enumerate the percentage of fluorescent cells in an embryo, we used transgenic zebrafish in combination with flow cytometry. 72 hpf transgenic embryos were grouped in samples of three and washed 3x with E3\[[@pone.0196872.ref060]\]. After the last wash, the E3 was removed, leaving 100 μL. 1 mL of 10 mM dithiothreitol (DTT) in E3 was added, and samples were incubated for 25 mins. Samples were than washed 3x with Dulbecco\'s phosphate-buffered saline (DPBS) containing Ca^2+^ and Mg^2+^. After the last wash, 500 μL of DPBS and 5 μL of 5 mg/mL (26U/mL) Liberase TM (Roche, Upper Bavaria, Germany) were added. Samples were incubated at 37°C on a horizontal orbital shaker at 180 rpm for 60 mins. Samples were than triturated with a P-1000 to ensure proper dissociation and transferred to a 5 mL polystyrene round bottom tube with cell strainer cap. 1 μL of SytoxRed (ThermoFisher Scientific, Waltham, MA) was added to each sample to mark dead cells. Samples were run through a BD Accuri C6 flow cytometer (BD Biosciences, San Jose, CA) and enumerated. Data were analyzed using FloJo software (FloJo LLC, Ashland, Oregon) to quantitate total percentage of positive fluorescent cells.

Quantitation of HSPCs in developing zebrafish embryos {#sec009}
-----------------------------------------------------

HSPC isolation and culture was performed as previously described\[[@pone.0196872.ref061]\]. Samples were given carp serum, Gcsf, and Epo to stimulate myeloid and erythroid differentiation\[[@pone.0196872.ref062], [@pone.0196872.ref063]\]. They were incubated at 32°C and 5% CO~2~ for 7--10 days and imaged with an Olympus IX53 inverted microscope (Olympus, Center Valley, PA) at 40x to enumerate colony forming units (CFUs).

RT-PCR {#sec010}
------

mRNA was extracted from ZKS, ZEST, CHEST, and whole kidney using a Qiagen RNAeasy kit (Qiagen, Hilden, Germany). To obtain myeloid, lymphoid, and precursor cells, fluorescence-activated cell sorting (FACS) was performed on whole kidney marrow (WKM)\[[@pone.0196872.ref031]\]; these populations are easily separated based on their size and granularity\[[@pone.0196872.ref057]\]. cDNA was then generated with the iScript cDNA synthesis kit (Biorad, Hercules, CA), and PCR was performed with Jumpstart ReadyMix Taq (Sigma-Aldrich, St. Louis, MO).

Quantitative RT-PCR (qRT-PCR) {#sec011}
-----------------------------

mRNA was extracted from embryos at 48 and 72 hpf using a Qiagen RNAeasy kit (Qiagen, Hilden, Germany). cDNA was then generated with the iScript cDNA synthesis kit (Biorad, Hercules, CA), and PCR was performed with SsoFast SYBR Mastermix (Biorad, Hercules, CA). Fold expression was measured as ΔΔCT using *ef1a\[[@pone.0196872.ref028]\]* as a reference gene and whole kidney cDNA as a reference tissue.

Statistics {#sec012}
----------

Relative fold change was done by setting the control as the standard. For triplicates, fold change per experiments were averaged and plotted with standard deviation. To discern statistical difference, data were analyzed using an unpaired two-tailed Student's T test. \* = p\<0.05, \*\* = p\<0.0001, and N.S. = no significance.

Results {#sec013}
=======

Zebrafish kidney stroma (ZKS) cells\[[@pone.0196872.ref050]\], zebrafish embryonic stromal trunk (ZEST) cells\[[@pone.0196872.ref048]\], and caudal hematopoietic embryonic stromal tissue (CHEST) cells\[[@pone.0196872.ref049]\] are hematopoietic-supportive stromal cell lines isolated and grown from adult and developing zebrafish. These stromal cell lines are derived from different physical locations of adult hematopoietic maintenance\[[@pone.0196872.ref064]\] (ZKS cells), embryonic HSC emergence\[[@pone.0196872.ref007], [@pone.0196872.ref008]\] (ZEST cells), and embryonic HSC expansion\[[@pone.0196872.ref065]\] (CHEST cells) at several key time points during hematopoietic development ([Fig 1A](#pone.0196872.g001){ref-type="fig"}) and support hematopoietic proliferation and differentiation of all blood cell types in culture\[[@pone.0196872.ref027], [@pone.0196872.ref048]--[@pone.0196872.ref050], [@pone.0196872.ref066], [@pone.0196872.ref067]\]. Therefore, we hypothesized that these cells would generate and secrete proteins required for hematopoiesis. Total RNA from each stromal cell line was isolated, sequenced, and compared to a non-supportive hematopoietic cell line (zebrafish fibroblast cells; ZF4\[[@pone.0196872.ref068]\]) to remove housekeeping genes from our analysis. RNA-seq of the supportive hematopoietic stromal cell lines identified 447 shared transcripts ([Fig 1B](#pone.0196872.g001){ref-type="fig"}; top genes involved in hematopoiesis are listed in [Table 1](#pone.0196872.t001){ref-type="table"}). Transcripts were analyzed as reads per kilobase of transcript per million reads mapped (RPKM), which normalized and accounted for transcript length. From these transcripts, *ism1* was chosen for further research due to its high RPKM levels across all three cell lines ([Fig 1C](#pone.0196872.g001){ref-type="fig"}), the fact that it is a secreted protein, and because it has a conserved ortholog in humans. To confirm that *ism1* was expressed in ZKS, ZEST, and CHEST stromal cells, we performed RT-PCR for *ism1*, validating its expression in these tissues ([S1 Fig](#pone.0196872.s001){ref-type="supplementary-material"}). We also observed *ism1* expression in whole kidney, the main site of hematopoiesis in the adult zebrafish\[[@pone.0196872.ref064]\]. To confirm that *ism*1 was only expressed in the stromal cells of the kidney, we fractionated cells from WKM using FACS; myeloid, lymphoid, and precursor cell populations can be easily separated based on their size and granularity\[[@pone.0196872.ref057]\]. RT-PCR analysis of these cells confirmed that *ism1* is expressed in the supportive hematopoietic tissues, but not in hematopoietic cells themselves ([S1 Fig](#pone.0196872.s001){ref-type="supplementary-material"}).

![*ism1* is highly expressed in hematopoietic-supportive stromal cell lines.\
(**A**) Each stromal cell line is derived from sites of hematopoietic emergence, expansion, and maintenance in adult and embryonic zebrafish; adult zebrafish kidney stroma (ZKS, derived from the adult kidney; pink\[[@pone.0196872.ref050]\]), zebrafish embryonic stromal trunk (ZEST, derived from the embryonic trunk; blue\[[@pone.0196872.ref048]\]), and caudal hematopoietic embryonic stromal tissue (CHEST, derived from the CHT; green\[[@pone.0196872.ref049]\]). (**B**) Each stromal cell line's transcriptome was analyzed with RNA-seq and compared to a non-hematopoietic supportive stromal cell line (ZF4); transcripts were plotted as a Venn diagram demonstrating 447 conserved transcripts. (**C**) *ism1* transcript levels for each cell line presented as reads per kilobase of transcript per million reads mapped (RPKM). See [Table 1](#pone.0196872.t001){ref-type="table"} for genes identified in this screen.](pone.0196872.g001){#pone.0196872.g001}
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###### Expression levels of highly expressed transcripts in hematopoietic supportive cell lines.

![](pone.0196872.t001){#pone.0196872.t001g}

  Gene ID (Zv9)        Gene name                                                                 Gene description                                                                                               RPKM (ZKS cells)   RPKM (ZEST cells)   RPKM (CHEST cells)
  -------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- ------------------ ------------------- --------------------
  ENSDARG00000056680   *stc2a*                                                                   Stanniocalcin 2a                                                                                               1171.390702        1231.42446          706.1714178
  ENSDARG00000015050   [*calm3a*](http://zfin.org/action/marker/view/ZDB-GENE-030131-5590)       Calmodulin 3a (phosphorylase kinase, delta)                                                                    398.2576181        445.6855878         969.0665779
  ENSDARG00000026726   [*anxa1a*](http://zfin.org/action/marker/view/ZDB-GENE-030131-6664)       Annexin A1a                                                                                                    386.1286169        280.2930981         417.0527221
  ENSDARG00000071498   [*fhl1a*](http://zfin.org/action/marker/view/ZDB-GENE-040206-1)           Four and a half LIM domains 1a                                                                                 392.740221         209.8129055         350.3135956
  ENSDARG00000055439   [*adamtsl7*](http://zfin.org/action/marker/view/ZDB-GENE-070816-2)        ADAMTS-like 7                                                                                                  377.7311012        296.1991765         268.6541787
  ENSDARG00000069752   [*ckba*](http://zfin.org/action/marker/view/ZDB-GENE-060929-902)          Creatine kinase, brain a                                                                                       410.942751         156.7429014         276.7297589
  ENSDARG00000016691   [*cd9b*](http://zfin.org/action/marker/view/ZDB-GENE-040426-2768)         CD9 antigen, b                                                                                                 506.2882968        266.2312285         66.00918816
  ENSDARG00000093440   [*tnfaip6*](http://zfin.org/action/marker/view/ZDB-GENE-060421-2654)      Tumor necrosis factor, alpha-induced protein 6                                                                 197.4394341        109.3081398         491.6323329
  ENSDARG00000038123   [*myl9a*](http://zfin.org/action/marker/view/ZDB-GENE-041010-120)         Myosin, light chain 9a, regulatory                                                                             179.6584981        96.56364658         511.0645904
  ENSDARG00000014626   [*dlx3b*](http://zfin.org/action/marker/view/ZDB-GENE-980526-280)         Distal-less homeobox gene 3b                                                                                   285.6044597        300.5094173         166.0309536
  ENSDARG00000087402   *tpm1*                                                                    Tropomyosin 1 (alpha)                                                                                          147.8702844        67.17783708         530.8673917
  ENSDARG00000029353   [*serpine2*](http://zfin.org/action/marker/view/ZDB-GENE-040426-848)      Serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2   155.1438879        185.8865435         362.6601572
  ENSDARG00000008359   [*cnn3a*](http://zfin.org/action/marker/view/ZDB-GENE-030131-5130)        Calponin 3, acidic a                                                                                           200.6466151        175.5868376         322.1817671
  ENSDARG00000013804   [*capns1b*](http://zfin.org/action/marker/view/ZDB-GENE-030131-5206)      Calpain, small subunit 1 b                                                                                     295.8800252        192.2972637         137.1191417
  ENSDARG00000062363   [*phex*](http://zfin.org/action/marker/view/ZDB-GENE-030103-2)            Phosphate regulating gene with homologues to endopeptidases on the X chromosome                                374.7902084        246.0473474         2.923096804
  ENSDARG00000007697   [*fabp7a*](http://zfin.org/action/marker/view/ZDB-GENE-000627-1)          Fatty acid binding protein 7, brain, a                                                                         195.9918097        237.0929702         156.4171196
  ENSDARG00000054749   [*lmo4b*](http://zfin.org/action/marker/view/ZDB-GENE-030131-3570)        LIM domain only 4b                                                                                             171.4754089        158.0390988         259.5479538
  ENSDARG00000040362   [*ehd2*](http://zfin.org/action/marker/view/ZDB-GENE-030131-9347)         EH-domain containing 2                                                                                         161.7766861        245.0843826         179.9114927
  ENSDARG00000012066   [*dcn*](http://zfin.org/action/marker/view/ZDB-GENE-010102-1)             Decorin                                                                                                        138.738941         110.0299673         294.5159175
  ENSDARG00000007396   [*rnd3b*](http://zfin.org/action/marker/view/ZDB-GENE-040718-331)         Rho family GTPase 3b                                                                                           230.919067         106.1477521         180.3513591
  ENSDARG00000075045   [*cxcl-c1c*](http://zfin.org/action/marker/view/ZDB-GENE-090313-165)      Chemokine (C-X-C motif) ligand C1c                                                                             205.5342189        222.3706168         85.84923297
  ENSDARG00000030449   [*crabp2b*](http://zfin.org/action/marker/view/ZDB-GENE-050208-52)        Cellular retinoic acid binding protein 2, b                                                                    105.0984741        221.8625863         181.7852462
  ENSDARG00000089187   [*wfdc2*](http://zfin.org/action/marker/view/ZDB-GENE-090313-47)          WAP four-disulfide core domain 2                                                                               215.3192844        100.2819887         173.5050759
  ENSDARG00000061226   [*timp2a*](http://zfin.org/action/marker/view/ZDB-GENE-030612-1)          Tissue inhibitor of metalloproteinase 2a                                                                       110.5132145        134.7435353         217.234448
  ENSDARG00000030694   [*atp6v1e1b*](http://zfin.org/action/marker/view/ZDB-GENE-020419-11)      ATPase, H+ transporting, lysosomal, V1 subunit E isoform 1b                                                    211.5850639        104.0432062         140.8175355
  ENSDARG00000016238   [*arl6ip5b*](http://zfin.org/action/marker/view/ZDB-GENE-040718-223)      ADP-ribosylation factor-like 6 interacting protein 5b                                                          180.1080903        105.0459892         159.1043514
  ENSDARG00000019307   [*dusp5*](http://zfin.org/action/marker/view/ZDB-GENE-010625-1)           Dual specificity phosphatase 5                                                                                 126.478358         236.8883821         68.27162288
  ENSDARG00000054823   [*id3*](http://zfin.org/action/marker/view/ZDB-GENE-020515-1)             Inhibitor of DNA binding 3                                                                                     123.0298414        119.957024          185.8068645
  ENSDARG00000096118   [*ost4*](http://zfin.org/action/marker/view/ZDB-GENE-110307-1)            Oligosaccharyltransferase 4 homolog                                                                            293.697141         56.14183101         47.90212635
  ENSDARG00000070391   [*tspan4b*](http://zfin.org/action/marker/view/ZDB-GENE-070410-127)       Tetraspanin 4b                                                                                                 124.4627775        134.439824          107.2748044
  ENSDARG00000002507   [*itga10*](http://zfin.org/action/marker/view/ZDB-GENE-100922-54)         Integrin, alpha 10                                                                                             89.61611629        201.1502394         71.71587866
  ENSDARG00000008363   [*mcl1b*](http://zfin.org/action/marker/view/ZDB-GENE-030825-1)           Myeloid cell leukemia sequence 1b                                                                              138.0029954        100.3628761         121.8545135
  ENSDARG00000078674   [*hspb9*](http://zfin.org/action/marker/view/ZDB-GENE-080214-6)           Heat shock protein, alpha-crystallin-related, 9                                                                208.1065389        130.9142075         9.6011956
  ENSDARG00000056627   [*cxcl14*](http://zfin.org/action/marker/view/ZDB-GENE-000619-1)          Chemokine (C-X-C motif) ligand 14                                                                              30.54406211        119.5273691         197.7629774
  ENSDARG00000026070   [*cd82b*](http://zfin.org/action/marker/view/ZDB-GENE-030131-2857)        CD82 antigen, b                                                                                                117.1867309        119.7501676         99.79403009
  ENSDARG00000032831   [*htra1a*](http://zfin.org/action/marker/view/ZDB-GENE-040704-64)         HtrA serine peptidase 1a                                                                                       62.04851894        79.54294838         191.2823828
  ENSDARG00000027088   [*ptgdsb*](http://zfin.org/action/marker/view/ZDB-GENE-030131-8436)       Prostaglandin D2 synthase b                                                                                    295.7620764        16.83617366         7.299828587
  ENSDARG00000069983   [*scinla*](http://zfin.org/action/marker/view/ZDB-GENE-030131-2005)       Scinderin like a                                                                                               229.2763242        77.71766924         12.73139596
  ENSDARG00000014103   [*dkk1a*](http://zfin.org/action/marker/view/ZDB-GENE-090313-406)         Dickkopf 1a                                                                                                    45.36030464        95.82598311         174.3537947
  ENSDARG00000044001   [*lgals3l*](http://zfin.org/action/marker/view/ZDB-GENE-030131-4324)      Lectin, galactoside-binding, soluble, 3 (galectin 3)-like                                                      151.485882         94.79980323         68.69664737
  ENSDARG00000094752   [*rpe65b*](http://zfin.org/action/marker/view/ZDB-GENE-050410-16)         Retinal pigment epithelium-specific protein 65b                                                                51.81279893        157.9199935         85.8643745
  ENSDARG00000006275   [*irf2bp2b*](http://zfin.org/action/marker/view/ZDB-GENE-040426-2574)     Interferon regulatory factor 2 binding protein 2b                                                              83.23427126        90.32706729         118.4504944
  ENSDARG00000096594   [*lratb*](http://zfin.org/action/marker/view/ZDB-GENE-060810-31)          Lecithin retinol acyltransferase b (phosphatidylcholine---retinol O-acyltransferase b)                         54.62075299        126.7544822         101.4833434
  ENSDARG00000045219   [*dkk1b*](http://zfin.org/action/marker/view/ZDB-GENE-990708-5)           Dickkopf 1b                                                                                                    115.2674028        123.3601222         41.36781122
  ENSDARG00000073891   [*gdf10b*](http://zfin.org/action/marker/view/ZDB-GENE-120316-1)          Growth differentiation factor 10b                                                                              33.67260166        219.1972506         6.710000293
  ENSDARG00000063704   [*gpr1*](http://zfin.org/action/marker/view/ZDB-GENE-091204-457)          G protein-coupled receptor 1                                                                                   11.47967914        67.08867022         174.2527408
  ENSDARG00000042690   [*s1pr1*](http://zfin.org/action/marker/view/ZDB-GENE-001228-2)           Sphingosine-1-phosphate receptor 1                                                                             51.05707689        120.3548169         69.24951973
  ENSDARG00000070420   [*cyp24a1*](http://zfin.org/action/marker/view/ZDB-GENE-060825-1)         Cytochrome P450, family 24, subfamily A, polypeptide 1                                                         18.72705544        177.0835255         44.13670934
  ENSDARG00000086842   [*dap1b*](http://zfin.org/action/marker/view/ZDB-GENE-000511-4)           Death associated protein 1b                                                                                    108.3112632        77.42847935         53.19516114
  ENSDARG00000068710   [*nid1a*](http://zfin.org/action/marker/view/ZDB-GENE-050302-58)          Nidogen 1a                                                                                                     62.19315736        114.8440231         50.83336553
  ENSDARG00000055381   [*bambia*](http://zfin.org/action/marker/view/ZDB-GENE-010416-1)          BMP and activin membrane-bound inhibitor homolog a                                                             88.97243166        57.43071367         78.67391423
  ENSDARG00000067742   [*eva1bb*](http://zfin.org/action/marker/view/ZDB-GENE-080204-108)        Eva-1 homolog Bb                                                                                               63.44368564        84.2765728          74.97828951
  ENSDARG00000005789   [*enpp1*](http://zfin.org/action/marker/view/ZDB-GENE-040724-172)         Ectonucleotide pyrophosphatase/ phosphodiesterase 1                                                            64.34284892        137.6726653         19.82855613
  ENSDARG00000056023   [*hoxb9a*](http://zfin.org/action/marker/view/ZDB-GENE-990415-109)        Homeo box B9a                                                                                                  69.19604476        83.45231228         68.31730246
  ENSDARG00000094857   [*dio2*](http://zfin.org/action/marker/view/ZDB-GENE-030327-4)            Deiodinase, iodothyronine, type II                                                                             79.95831483        112.2283984         26.87641183
  ENSDARG00000089078   *col23A1*                                                                 Collagen, type XXIII, alpha 1                                                                                  63.62339938        147.7007832         2.289688031
  ENSDARG00000030177   [*uchl3*](http://zfin.org/action/marker/view/ZDB-GENE-050522-158)         Ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)                                              105.7558676        48.45357406         49.98198164
  ENSDARG00000024877   [*ptgr1*](http://zfin.org/action/marker/view/ZDB-GENE-041212-80)          Prostaglandin reductase 1                                                                                      103.6331577        54.73419065         37.55761808
  ENSDARG00000094854   [*ms4a17a*.*8*](http://zfin.org/action/marker/view/ZDB-GENE-070705-365)   Membrane-spanning 4-domains, subfamily A, member 17A.8                                                         116.1375676        55.21694763         23.36757024
  ENSDARG00000019128   [*tpm4b*](http://zfin.org/action/marker/view/ZDB-GENE-030131-2964)        Tropomyosin 4b                                                                                                 54.49279439        41.58138656         98.05974096
  ENSDARG00000058348   [*scinlb*](http://zfin.org/action/marker/view/ZDB-GENE-040426-2068)       Scinderin like b                                                                                               43.90721933        56.88955333         90.22067671
  ENSDARG00000005541   [*wif1*](http://zfin.org/action/marker/view/ZDB-GENE-990712-17)           Wnt inhibitory factor 1                                                                                        93.47095208        67.6434638          28.05685047
  ENSDARG00000010462   [*sp9*](http://zfin.org/action/marker/view/ZDB-GENE-040426-2313)          Sp9 transcription factor                                                                                       57.92009712        49.7884664          76.65945541
  ENSDARG00000044803   [*dhrs3b*](http://zfin.org/action/marker/view/ZDB-GENE-041010-172)        Dehydrogenase/reductase (SDR family) member 3b                                                                 130.0154057        51.68314191         1.624036879
  ENSDARG00000087263   [*ssr3*](http://zfin.org/action/marker/view/ZDB-GENE-030131-9134)         Signal sequence receptor, gamma                                                                                91.92315352        47.64499378         39.03838439
  ENSDARG00000058733   [*ihha*](http://zfin.org/action/marker/view/ZDB-GENE-051010-1)            Indian hedgehog homolog a                                                                                      7.794542694        88.86938529         78.16679263
  ENSDARG00000015966   [*yaf2*](http://zfin.org/action/marker/view/ZDB-GENE-041210-115)          YY1 associated factor 2                                                                                        67.3993785         69.0931997          38.15094538
  ENSDARG00000090945   *clec4f*                                                                  C-type lectin domain family 4, member F                                                                        120.1210729        48.41536445         3.207217092
  ENSDARG00000042296   [*dlx5a*](http://zfin.org/action/marker/view/ZDB-GENE-990415-49)          Distal-less homeobox gene 5a                                                                                   126.8385026        31.88420836         12.30766798
  ENSDARG00000053381   *ppap2a*                                                                  Phosphatidic acid phosphatase type 2A                                                                          36.20007779        67.05858162         65.57173276
  ENSDARG00000069376   [*tnfsf12*](http://zfin.org/action/marker/view/ZDB-GENE-060929-376)       Tumor necrosis factor (ligand) superfamily, member 12                                                          38.06281765        121.2490869         7.954191675

All transcripts are presented as reads per kilobase of transcript per million reads mapped (RPKM). Each stromal cell line's transcriptome was analyzed and compared to a non-hematopoietic supportive stromal cell line (ZF4). The transcripts below have been described previously as playing a role in hematopoiesis.

*ism1* morphants exhibit reduced erythrocyte production {#sec014}
-------------------------------------------------------

To elucidate *ism1's* role in erythroid cell production, *gata1a*:DsRed transgenic zebrafish were used; Gata1 is a transcription factor expressed in erythrocytes, allowing for real time visualization of red blood cells in developing embryos. *ism1* knockdown with a specific MO caused slowed circulation and caused blood to pool in *gata1a*:DsRed^+^ zebrafish ([Fig 2A](#pone.0196872.g002){ref-type="fig"}) when examined at 48 hpf. The control group expressed no abnormalities with respect to blood circulation, compared to 38% of the *ism1* morphants. The hearts of embryos injected with *ism*1 MO were pumping and appeared morphologically normal. Additionally, no blood was observed leaking from blood vessels. Injection of *ism1* mRNA reduced the amount of pooled blood seen in *ism1* morphants and increased the speed of erythrocyte circulation ([Fig 2B](#pone.0196872.g002){ref-type="fig"}).

![*ism1* knockdown decreases erythrocytes.\
*gata1*:DsRed zebrafish embryos were injected at the single-cell-stage with 7 ng *ism1* MO (MO), or 7 ng *ism1* MO and 17.88 ng of *ism1* mRNA (Rescue); uninjected embryos served as controls. (**A**) 24 hpf zebrafish visualized at 5x that have normal (left), pooled blood (middle), and slowed circulation (right) phenotypes. (**B**) Quantitation of zebrafish shown in (**A**); pooled blood (yellow), slowed circulation (blue), and normal (red) phenotypes. (**C**) Flow cytometry results quantitating *gata1*:DsRed^+^ erythrocytes in uninjected (control; red), *ism1* MO injected (MO; peach), and *ism1 MO* with *ism1* mRNA (Rescue; pink) 72 hpf zebrafish. (**D**) qRT-PCR was performed comparing transcript levels of *hbaa* in *ism1* MO injected (MO) and uninjected controls (control). Bars represent the mean, and error bars represent standard deviation. Data was normalized as fold change over control and analyzed using a two-tailed unpaired Student's T test. \* denotes p\<0.05, \*\* denotes p\<0.0001, N.S indicates no significance.](pone.0196872.g002){#pone.0196872.g002}

Regardless of their circulation phenotypes, we speculated that the morphant embryos also had decreased numbers of erythrocytes. To quantitate total red blood cell numbers, flow cytometry was utilized. All *ism1* MO injected embryos were analyzed without grouping them based on their circulation phenotype. Three individual 72 hpf *gata1a*:DsRed^+^ *ism1* MO injected zebrafish were randomly grouped together, enzymatically dissociated in a sample tube, and analyzed on a flow cytometer to quantitate *gata1a*:DsRed^+^ cells. Percentages of *gata1a*:DsRed^+^ cells were normalized to uninjected control embryos and expressed as fold change over control. *ism1* knockdown caused an approximate 2-fold decrease in *gata1*:DsRed^+^ cells compared to control ([Fig 2C](#pone.0196872.g002){ref-type="fig"}) and the rescued group displayed erythrocyte levels similar to control groups ([Fig 2C](#pone.0196872.g002){ref-type="fig"}), indicating that *ism1* depletion was the cause of the erythrocyte defect. Additionally, *ism1* MO injected whole embryos were pooled into groups of 10, digested, and qRT-PCR was used to analyze alpha globin *(hbaa)* mRNA levels, a specific marker of differentiated erythrocytes. qRT-PCR demonstrated a 29-fold reduction of *hbaa* mRNA levels in *ism1* MO injected animals ([Fig 2D](#pone.0196872.g002){ref-type="fig"}). Taken together, these data indicate that *ism1* reduction causes a decrease in embryonic erythrocytes and a decrease in *hbaa* mRNA levels in the whole organism.

While intersegmental vessels (ISVs) are not involved in blood development, previous studies indicated that *ism1* was necessary for proper development of ISVs in zebrafish\[[@pone.0196872.ref055]\]. To confirm that *ism1* was not necessary for the formation of the dorsal aorta, the source of HSC generation during development, we injected *ism1* MO into the vasculature-specific *kdrl*:EGFP zebrafish transgenic line. 24 hpf zebrafish were visualized and exhibited shortened ISVs, as reported previously ([S2 Fig](#pone.0196872.s002){ref-type="supplementary-material"})\[[@pone.0196872.ref055]\]. However, the dorsal aorta was not negatively affected in morphants ([S2 Fig](#pone.0196872.s002){ref-type="supplementary-material"}), also in agreement with previous studies\[[@pone.0196872.ref055]\]. Although not previously described, the shortened ISVs recovered by 48 hpf without addition of exogenous *ism1*. In conclusion, *ism1* morphants experience a reduction in ISVs that recovers by 48 hpf but have a normal dorsal aorta.

*ism1* morphants exhibit reduced myeloid cells {#sec015}
----------------------------------------------

Myeloid cells such as neutrophils and macrophages are cellular components critical for innate immune responses. To investigate *ism1*'s role in myeloid cell biology, *mpx*:EGFP transgenic zebrafish were utilized. *mpx*:EGFP zebrafish embryos were injected with *ism1* MO; all injected embryos were visualized and total *mpx*:EGFP^+^ cells were individually enumerated at 48 hpf ([Fig 3A](#pone.0196872.g003){ref-type="fig"}). *ism1* MO injection resulted in a 20% reduction of *mpx*:EGFP^+^ cells compared to control groups ([Fig 3B](#pone.0196872.g003){ref-type="fig"}) and rescue with *ism1* mRNA showed a recovery of *mpx*:EGFP^+^ cells compared to *ism1* MO injected embryos. qRT-PCR was performed on pools of 10 injected embryos for colony stimulating factor 3 receptor (*csf3r;* also called granulocyte colony stimulating factor receptor), and colony stimulating factor 1 receptor (*csf1r;* also called macrophage colony stimulating factor receptor), two markers for neutrophils and macrophages, respectively. qRT-PCR indicated a 11-fold reduction in *csf3r* mRNA levels and a 30% reduction of *csf1r* mRNA levels in *ism1* MO injected embryos ([Fig 3C](#pone.0196872.g003){ref-type="fig"}). Overall, these data indicate that *ism1* knockdown causes a reduction in *mpx*:EGFP^+^ myeloid cells.

![*ism1* knockdown decreases neutrophils and macrophages in 48 hpf zebrafish.\
*mpx*:GFP single-cell-stage embryos were injected with 7 ng *ism1* MO (MO; squares), or 7 ng *ism1* MO and 17.88 ng of *ism1* mRNA (Rescue; triangles); uninjected embryos served as controls (circles). (**A**) Developing 48 hpf zebrafish were visualized, and individual *mpx*:GFP^+^ cells were enumerated; representative fish shown for reference. (**B**) Each data point represents total amount of *mpx*:GFP^+^ cells present in one zebrafish. (**C**) qRT-PCR was performed comparing transcript levels of *csf3r* (left) and *csf1r* (right) in *ism1* MO injected (MO) and uninjected controls (control) at 48 hpf. Bars represent the mean, and error bars represent standard deviation. A two-tailed unpaired Student's T test was performed to determine statistical significance. \* denotes p\<0.05, \*\* denotes p\<0.0001, N.S indicates no significance.](pone.0196872.g003){#pone.0196872.g003}

HSPCs are reduced in *ism1* morphants {#sec016}
-------------------------------------

To confirm that *ism1* loss was causing a reduction in HSPCs, groups of 10 MO-injected embryos at 48 hpf were placed in a tube, enzymatically digested, and plated in methylcellulose with exogenous hematopoietic-supportive growth factors\[[@pone.0196872.ref061]\]. After plating, the embryos were incubated for 7 days, allowing HSPCs to proliferate and differentiate ([Fig 4A](#pone.0196872.g004){ref-type="fig"}). Fish were not phenotypically selected before digestion; all injected fish were randomly pooled into groups of 10 and plated in methylcellulose. *ism1* MO injected and rescued embryos generated hematopoietic colonies, which were enumerated. Colony forming units (CFUs) for *ism1* MO injected zebrafish were reduced by 35% compared to control and rescue groups ([Fig 4B](#pone.0196872.g004){ref-type="fig"}). There was no statistical difference between control and rescue groups, indicating that *ism1* is necessary for the generation of the proper numbers of HSPCs in developing zebrafish embryos. qRT-PCR on 48 hpf embryos was also performed to quantitate HSPC-related transcription factors. Data showed an overall 20-fold reduction in *runx1*, and a 10-fold reduction in *cmyb* mRNA levels between controls and *ism1* MO injected embryos ([Fig 4C](#pone.0196872.g004){ref-type="fig"}). Overall, these data indicate that HSPC formation is reduced in *ism1* morphants.

![Hematopoietic stem and progenitor cells (HSPCs) are reduced in *ism1* knockdown embryos.\
Single-cell-stage embryos were injected with 7 ng of *ism1* MO (MO), or 7 ng of *ism1* MO and 17.88 ng of *ism1* mRNA (Rescue); uninjected embryos served as a control. (**A**) Ten 48 hpf embryos from each treatment were digested, plated in methylcellulose with exogenous hematopoietic-supportive growth factors, and incubated for 7 days. (**B**) Colony forming units (CFUs) generated by *ism1* MO (light blue) and *ism1* MO with *ism1* mRNA (Rescue; darker blue) injected embryos presented as fold change over control embryos (dark blue). (**C**) qRT-PCR was performed comparing transcript levels of *cmyb* and *runx1* in *ism1* MO injected (MO) and uninjected controls (control) at 48 hpf. Bars represent the mean, and error bars represent standard deviation. A two-tailed unpaired Student's T test was performed to determine statistical significance. \* denotes p\<0.05, \*\* denotes p\<0.0001, N.S indicates no significance.](pone.0196872.g004){#pone.0196872.g004}

Discussion {#sec017}
==========

In this study, we sought to elucidate molecular requirements for HSPC generation, support, and expansion. Utilizing previously described zebrafish hematopoietic-supportive stromal cell lines\[[@pone.0196872.ref048]--[@pone.0196872.ref050]\] we identified highly expressed transcripts determined by RNA-seq. *ism1* was chosen from this list due to its involvement in angiogenesis\[[@pone.0196872.ref055], [@pone.0196872.ref069]\], its presence in embryonic\[[@pone.0196872.ref052], [@pone.0196872.ref054], [@pone.0196872.ref055]\] and adult\[[@pone.0196872.ref053], [@pone.0196872.ref054]\] hematopoietic tissue, the fact that it is a secreted protein\[[@pone.0196872.ref052], [@pone.0196872.ref053], [@pone.0196872.ref055]\], and because it shares synteny with human *ISM1*. Our study findings indicate that *ism1* is required for proper embryonic hematopoiesis.

To elucidate *ism1*'s role in hematopoiesis we performed loss-of-function experiments using MOs to generate *ism1* morphants. Other MOs have been utilized to study *ism1*\[[@pone.0196872.ref055]\], and our MO was directed towards a similar location in the genome 8bp 3' of Xiang *et*. *al's* translation-blocking MO; the location we chose was suggested by modeling software to be a more effective site for blocking *ism1* translation. The MO we designed binds 10bp 5' to *ism1*'s start site; as two splice variants are predicted for *ism1*, we wanted to ensure that the MO blocked all versions of Ism1 so we would not have multiple splice isoforms potentially confounding our results. Importantly, our MO and Xiang *et*. *al*'s have the same phenotypic effect on ISV formation early in development. The dorsal aorta, the site of HSPC generation between 36--52 hpf\[[@pone.0196872.ref007], [@pone.0196872.ref008]\], was unaffected (our data and \[[@pone.0196872.ref055]\]). We also observed that ISVs were only affected between 24--48 hpf, after which ISV branching was normal. To observe hematopoietic defects, we injected *ism1* MOs into previously characterized transgenic fish lines that have fluorescent proteins expressed in specific hematopoietic cell lineages. *ism1* morphants did not express any morphological defects such as bent tails, spinal deformation, or stunted growth (data not shown). However, they did have phenotypes in their hematopoietic tissues. Coupled with the fact that these phenotypes were rescued by the addition of exogenous *ism1* mRNA indicates that Ism1 is a key protein involved in normal zebrafish hematopoiesis.

It is important to note that we are utilizing zebrafish as a model system to investigate the evolution of vertebrate hematopoiesis. While mammals are derived from lobe-finned fish and zebrafish are ray-finned fish (reviewed in \[[@pone.0196872.ref070]\]), zebrafish have proven to be an excellent model of hematopoiesis; their molecular control of blood formation and differentiation is well conserved with mammals\[[@pone.0196872.ref024]--[@pone.0196872.ref026], [@pone.0196872.ref071]\]. Further evidence of this is that drugs identified in zebrafish are now being utilized in the clinic to treat human blood diseases\[[@pone.0196872.ref072]\]. One concern with using zebrafish as a model is that the MO may not be specific for only one copy of *ism1*. While the genome was duplicated early in teleost evolution\[[@pone.0196872.ref073], [@pone.0196872.ref074]\], there is only one described copy of *ism1* in the zebrafish genome; we found no additional copies in our scanning of genomic data and RNA-seq results, in agreement with others\[[@pone.0196872.ref055]\]. This one copy of zebrafish *ism1* shares synteny with human *ISM1*; *JAG1* (*jag1b*), *BTBD3* (*btbd3b*), and *SPTLC3* (*sptlc3*) are 5' to *ISM1* (*ism1*), while *TASP1* (*tasp1*), *KIF16B* (*kif16bb*), and *FLRT3* (*flrt3*) are 3'. The only other genes in the zebrafish *ism1* family are *ism2a* and *ism2b*. These two *isthmin* paralogs are located on different chromosomes (*ism1* is on chromosome 13, *ism2a* is on 17, and *ism2b* is on 20) and share synteny with only the genes on the 5' side of human *ISM2*. Little is known about *ism2a* or *ism2b*'s roles/functions in zebrafish. These genes share no synteny with *ISM1* or *ism1*, indicating that *ism2a* and *ism2*b are likely different genes as opposed to duplicates of *ism1*. There are 9 *ism1* orthologs in other fish species like cod, amazon molly, fugu, medaka, platyfish, spotted gar, stickleback, tetraodon, and tilapia, all of which only have one identified copy of *ism1* in their genome. Overall, it appears that *ism1* only has one identifiable copy in the zebrafish genome, is not mislabeled, and is similar to human *ISM1*.

To examine the role of *ism1* in hematopoiesis, we first examined erythrocytes due to their abundance and importance during development; they are also the first hematopoietic cells to arise. *gata1a*:DsRed^+^ *ism1* morphants exhibited pooled blood and we observed what appeared to be slowed circulation. While some "pooled blood" phenotypes have been attributed to functional cardiac defects\[[@pone.0196872.ref075]\], no such phenotype was visualized in our experiments. This suggested that the morphant's vasculature might be disrupted, but our data, in agreement with prior studies\[[@pone.0196872.ref055]\], did not see a disruption of the dorsal aorta after *ism1* knockdown. To further confirm that erythrocytes were specifically reduced, we enumerated them with flow cytometry and found a significant decrease in erythrocytes in *ism1* morphants. Reduction of erythrocytes was further validated by qRT-PCR data showing reduction of the *hbaa* transcript, a hemoglobin gene. In conclusion, *ism1* knockdown caused an overall reduction of erythrocytes and the phenotype was rescued by the addition of exogenous *ism1* mRNA, indicating that *ism1* is required for normal erythropoiesis.

*mpx*:GFP zebrafish express GFP in both neutrophils and macrophages\[[@pone.0196872.ref058], [@pone.0196872.ref063]\]; both are differentiated myeloid cell lineages. *ism1* morphants had a 20% reduction in these myeloid cells, suggesting that myeloid cell lineages were not properly forming. We also saw a reduction in *csf3r* transcript, the signaling receptor necessary for granulocyte formation and differentiation, measured by qRT-PCR. While *ism1* morphants exhibited an overall decrease in myeloid cells, these cell lineages were still generated, suggesting that *ism1* isn't required for myeloid differentiation but is necessary for the generation or proliferation of myeloid HSPCs. Together, the reduction in both myeloid and erythroid cell lineages suggested a reduction of a common upstream progenitor cell. Therefore, *ism1* is likely involved in the proliferation or differentiation of a multipotent progenitor such as the CMP or HSC.

Together, decreased production of differentiated erythroid and myeloid cell lineages indicated that *ism1* knockdown somehow decreased the generation or proliferation of HSPCs during development. To investigate this possibility, we developed a surrogate assay to assess HSPC numbers in morphant zebrafish embryos\[[@pone.0196872.ref061]\]. This assay involved plating dissociated whole zebrafish embryos and adding exogenous factors that promote only HSPC differentiation and proliferation *in vitro*\[[@pone.0196872.ref062], [@pone.0196872.ref063], [@pone.0196872.ref076]\]. Plating HSPCs generates CFUs that arise from a single progenitor cell. Therefore, the number of CFUs counted after 7 days in culture corresponds to the number of total progenitor cells present in the organism at the time they were assayed. These results suggest that *ism1* is transcribed, translated, and secreted by stromal cells during a window of HSPC formation in the embryo; reducing *ism1* expression during this time reduced the number of HSPCs in the developing zebrafish. This non-cell-autonomous effect of *ism1* is seen with the clonal methylcellulose assay- because less Ism1 is secreted by the hematopoietic stroma during development, less HSPCs are generated in the embryo. 48 hpf was chosen for these assays due to the fact that functional HSPCs are generated by this time in development\[[@pone.0196872.ref007], [@pone.0196872.ref008], [@pone.0196872.ref027]--[@pone.0196872.ref030]\]. Our data, in agreement with previous studies\[[@pone.0196872.ref054]\], indicates that *ism1* is expressed in the hematopoietic stroma, but not in hematopoietic cells themselves. These results reinforce that Ism1 is a secreted protein made in the stromal niche, and not produced by HSPCs themselves; HSPCs are present in the "precursor"\[[@pone.0196872.ref062], [@pone.0196872.ref063], [@pone.0196872.ref076], [@pone.0196872.ref077]\] and "lymphoid"\[[@pone.0196872.ref029], [@pone.0196872.ref057], [@pone.0196872.ref062], [@pone.0196872.ref063], [@pone.0196872.ref076], [@pone.0196872.ref077]\] fractions of blood cells analyzed in this study. Importantly, this was not a developmental delay; plating dissociated *ism1* morphant embryos at later time points did not rescue the number of HSPC-derived colonies present (data not shown). Overall, the fact that HSPCs are reduced in *ism1* morphants likely accounts for the decreased counts of differentiated erythroid and myeloid lineages, suggesting that *ism1* is needed for normal levels of HSPC formation and differentiation during embryonic development.

*ism1* is extremely enigmatic, and many seemingly conflicting roles for this gene exist in the literature. *ism1* was originally identified as a secreted protein expressed along with fibroblast growth factor (Fgf) 8 in the *Xenopus* midbrain-hindbrain organizer\[[@pone.0196872.ref052]\], and it has recently been described in craniofacial patterning in humans\[[@pone.0196872.ref078]\]. Importantly, it has been identified in multiple embryonic tissues, many of which are involved in various regions of embryonic development. Of interest for blood formation, *ism1* was identified in *Xenopus* blood islands\[[@pone.0196872.ref052]\] and the lateral plate mesoderm of chicks and mice\[[@pone.0196872.ref054]\], which is tissue that gives rise to blood. It is also found in bone marrow\[[@pone.0196872.ref054]\], the site of adult hematopoiesis in mammals. While *ism1* was identified in the supportive hematopoietic stroma and not actual blood cells (our data and \[[@pone.0196872.ref054]\]), other studies indicate Ism1 is expressed in specific subsets of mouse lymphoid cells, including T and natural killer (NK) cells\[[@pone.0196872.ref053]\]. Our data does not correlate with this; zebrafish T and NK cells are present in the "lymphoid" population of WKM\[[@pone.0196872.ref057]\], and we detected no *ism1* in this fraction, indicating that this may be a difference between fish and mammals. Another difference across species is the description of *ism1* as an angiogenesis inhibitor; in mice exogenous ISM1 suppressed tumor angiogenesis\[[@pone.0196872.ref055], [@pone.0196872.ref069]\], but in zebrafish the knockdown of *ism1* reduced the growth of intersegmental vessels\[[@pone.0196872.ref055]\]. While *Ism1* plays a role in apoptosis, its role in this process is also complicated. It specifically reduces endothelial cell (EC) growth by inducing apoptosis\[[@pone.0196872.ref055], [@pone.0196872.ref069]\], while it has little to no effect on the proliferation or survival of glioma cells\[[@pone.0196872.ref069]\], NIH3T3 fibroblasts\[[@pone.0196872.ref055]\], Swiss 3T3 fibroblasts\[[@pone.0196872.ref055]\], B16 melanoma cells\[[@pone.0196872.ref055]\], and hepatocellular carcinoma cells\[[@pone.0196872.ref055]\]. This differential apoptotic capacity is not just different across cell types; it is linked to the solubility of ISM1. Soluble ISM1 causes apoptosis, while extracellular matrix (ECM)-immobilized ISM1 promotes EC adhesion, migration, and survival\[[@pone.0196872.ref079]\]. Unfortunately, no zebrafish-specific Ism1 antibody exists, preventing analysis of this in our experiments. It is important to note that the role of Ism1-induced apoptosis of hematopoietic cells is a possibility that could also explain a reduction in blood cells; further investigation may shed light on this subject.

Overall, these findings demonstrate a new role for *ism1;* its involvement in *de novo* hematopoietic cell formation. *ism1* reduction negatively impacted the number of HSPCs formed and their ability to properly generate mature erythrocytes, neutrophils, and macrophages. This could be due to *ism1* affecting a variety of signaling pathways; we speculate that *ism1* is involved in molecular pathways that instruct HSPC formation and differentiation, as its knockdown decreases various mature blood cell lineages. This is of keen interest, because *ism1* is secreted by our hematopoietic-supportive cell lines and affects various cell lineages, yet it has only been identified in a handful of tissues\[[@pone.0196872.ref052]--[@pone.0196872.ref055], [@pone.0196872.ref078]\] and lymphoid cells\[[@pone.0196872.ref053]\]. *ism1* expression is present in *Xenopus* blood islands suggesting its role in generating primitive blood\[[@pone.0196872.ref052]\]. This expression also implicates its importance in definitive hematopoiesis, as primitive erythropoiesis expresses many of the same molecular factors as its definitive counterpart\[[@pone.0196872.ref080]\]. *ism1* is also expressed at the same time and in the same location as *Xenopus* Fgf8 in the notochord\[[@pone.0196872.ref052]\]; it is also present in the zebrafish notochord\[[@pone.0196872.ref055]\]. FGF signaling is involved in hematopoiesis\[[@pone.0196872.ref081]--[@pone.0196872.ref087]\] as it is a mediator of Notch and Wnt signaling\[[@pone.0196872.ref083]\]. It is also modulated by BMP signaling\[[@pone.0196872.ref082]\]. All of these pathways are required for HSC production. Interestingly, *ism1* is a Wnt target\[[@pone.0196872.ref056]\] that is expressed (and likely secreted from) the notochord\[[@pone.0196872.ref052], [@pone.0196872.ref055]\]; this is the first time a secreted signal from the notochord has been implicated in hematopoietic development. Overall, these previous studies and our results indicate *ism1* is signaling to induce formation and functionality of hematopoietic tissues in the developing zebrafish. Further investigation of *ism1*'s role in this process may shed light on an important signaling pathway for blood formation and regulation.

Supporting information {#sec018}
======================

###### *ism1* is expressed in hematopoietic-supportive stromal cells but not in hematopoietic cells.

RT-PCR was performed for *ism1* from ZKS, ZEST, CHEST, and kidney mRNA. Myeloid, lymphoid, and precursor cell mRNA isolated from zebrafish kidney was also interrogated for *ism1* transcripts.

(TIF)

###### 

Click here for additional data file.

###### *ism1* knockdown leads to temporally shortened intersegmental vessels.

*flk1*:GFP single-cell-stage embryos were injected with 7 ng of *ism1* MO (bottom); uninjected embryos served as controls (top). 24 hpf (left column) and 48 hpf (right column) zebrafish were visualized at 40x for *flk1*:GFP fluorescence within the trunk area denoted by black box in brightfield image at top center. Arrows indicate shortened intersegmental vessels in *ism1* morphants. Numbers in corner of images denote the number of embryos displaying the imaged phenotype.

(TIF)

###### 

Click here for additional data file.
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